Loading market dashboard
Harmony Biosciences Holdings, Inc.
HRMYHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Harmony Biosciences Holdings, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $1.26B | $1.12B - $1.34B | $401.27M | $5.407 | 5 |
| Dec 2029 | $1.47B | $1.31B - $1.57B | $467.79M | $6.334 | 5 |
| Dec 2028 | $1.26B | $1.26B - $1.26B | $401.19M | $4.796 | 10 |
| Dec 2027 | $1.15B | $953.07M - $1.27B | $365.62M | $4.129 | 8 |
| Dec 2026 | $1.01B | $978.48M - $1.02B | $321.50M | $3.429 | 9 |
| Dec 2025 | $865.06M | $864.86M - $865.26M | $275.26M | $3.203 | 6 |
| Dec 2024 | $714.38M | $714.34M - $714.41M | $227.31M | $2.355 | 5 |
| Dec 2023 | $656.11M | $584.02M - $699.18M | $208.77M | $1.985 | 2 |
| Dec 2022 | $436.79M | $427.56M - $450.70M | $101.06M | $2.787 | 1 |
| Dec 2021 | $303.77M | $297.35M - $313.44M | $202.64M | $0.64 | 2 |
| Dec 2020 | $155.21M | $151.93M - $160.15M | $40.83M | -$0.585 | 2 |